1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ALNYLAM PHARMACEUTICALS INC
Alnylam Pharmaceuticals Inc XNAS: ALNY

Alnylam Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the m...

Read More
455.03 3.03 (0.67%)
Near 52W High of $469.81
902.3K
XNAS Volume

XNAS 08 Sep, 2025 4:19 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The board meeting for Alnylam Pharmaceuticals Inc is scheduled for today, for the purpose of Morgan Stanley 23rd Annual Global Healthcare Conference See details
Durability score
Low Financial Strength
11.1 / 100
Valuation Score
Expensive Valuation
4.8 / 100
Momentum Score
Technically Moderately Bullish
63.9 / 100
Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM
Analyst Price Target
421
1Yr Price target downside is -7%
27 analysts

20

S

6

W

4

O

1

T

SWOT Analysis

Alnylam Pharmaceuticals Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..